Medtronic conducted a post market clinical follow-up (pmcf) survey to seek out potential new risks and assess performance of the protégé peripheral stent systems (the gps self-expanding peripheral and biliary stent system and the protégé rx self-expanding carotid stent system).Survey results from a vascular surgeon in practice 15 years: physician has been using both protégé rx self-expanding peripheral and carotid stent system and protégé gps self-expanding peripheral and biliary stent systems since 2018, using 65 protégé rx self-expanding peripheral and carotid stent systems and 40 protégé gps self-expanding peripheral and biliary stent systems within the last year.The protégé rx self-expanding peripheral and carotid stent systems were used as follows: 30 to treat occlusions or lesions that are at high risk for abrupt closure or threatened closure following percutaneous transluminal angioplasty (pta); 20 to treat lesions that appear to be at high risk for restenosis following pta in the common iliac, external iliac, or subclavian arteries; and 15, to treat stenoses of the common carotid artery (cca), internal carotid artery (ica), and carotid bifurcation the protégé gps self-expanding peripheral and biliary stent system was used to treat: 15 occlusions or lesions that are at high risk for abrupt closure or threatened closure following percutaneous transluminal angioplasty (pta), 10 lesions that appear to be at high risk for restenosis following pta in the common iliac, external iliac, or subclavian arteries, and 15 palliative treatment of malignant neoplasms in the biliary tree.During use of the protégé rx self-expanding peripheral and carotid stent system, the following complications were encountered and associated with any percutaneous procedure: arrhythmia (1 patient), and hematoma (2 patients).An occurrence of surgical or endovascular intervention (1 patient) is reported as being associated with pta and stent placement.An occurrence of hypotension or hypertension in 1 patient is listed as associated with carotid interventions.During use of the protégé gps self-expanding peripheral and biliary stent system, one fever event has been reported as deemed associated with the percutaneous procedure an occurrence of gastrointestinal bleeding due to anticoagulation is reported as being associated with pta and stent placement.No complications are reported associated with biliary interventions.No of the above complications (adverse events) reported as listed as being related to device.
|